Cargando…
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
Leishmaniasis is a vector-borne parasitic disease caused by Leishmania species. The disease affects humans and animals, particularly dogs, provoking cutaneous, mucocutaneous, or visceral processes depending on the Leishmania sp. and the host immune response. No vaccine for humans is available, and t...
Autores principales: | Olías-Molero, Ana Isabel, de la Fuente, Concepción, Cuquerella, Montserrat, Torrado, Juan J., Alunda, José M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703564/ https://www.ncbi.nlm.nih.gov/pubmed/34946102 http://dx.doi.org/10.3390/microorganisms9122500 |
Ejemplares similares
-
Leishmania infantum infection does not affect the main composition of the intestinal microbiome of the Syrian hamster
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2022) -
Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2023) -
Scientometric analysis of chemotherapy of canine leishmaniasis (2000–2020)
por: Olías-Molero, A. I., et al.
Publicado: (2021) -
Immunization against Lamb Haemonchosis with a Recombinant Somatic Antigen of Haemonchus contortus (rHcp26/23)
por: García-Coiradas, Leticia, et al.
Publicado: (2010) -
Early antibody response and clinical outcome in experimental canine leishmaniasis
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2019)